Faes Farma

FAE.MC Small Cap

Healthcare · Drug Manufacturers - Specialty & Generic

Updated: Apr 5, 2026, 17:43 UTC

€4.70

-0.95% today

52W: €3.51 – €5.44

52W Low: €3.51 Position: 61.4% 52W High: €5.44

🔗 Compare Brokers

Key Metrics

P/E Ratio

18.78x

Price-to-Earnings

Forward P/E

13.51x

Forward Price/Earnings

P/S Ratio

2.33x

Price-to-Sales

EV/EBITDA

15.74x

Enterprise Value/EBITDA

Div. Yield

381%

Annual dividend yield

Market Cap

$1.5B

Market Capitalization

Revenue Growth

47.7%

YoY Revenue Growth

Profit Margin

12.7%

Net profit margin

ROE

10.82%

Return on Equity

Beta

0.32

Market sensitivity

Short Interest

—

% of float sold short

Avg. Volume

170,656

Average daily volume

Valuation Analysis

Signal

Fair

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

None

4 analysts

Avg. Price Target

€5.30

+12.89% upside

Target Range

€4.45 – €6.00

About the Company

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It engages in chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants services, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, securities and real estate, patents, trademarks and registered brands and equity interests. The company also provides animal nutrition and health products. It offers products for various therapeutic areas. Faes Farma, S.A. was incorporated in 1933 and is hea

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic Country: Spain Exchange: MCE